CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

RBC Capital Adjusts Biogen Price Target to $242 From $227, Maintains Outperform Rating

Positive
AI Analysis

Summary

RBC Capital increased its price target for Biogen from $227 to $242 while maintaining an Outperform rating.

Importance:2/10
Sentiment:
0.30
price targetanalyst ratingequity research
Related Companies

Read the original article

Published by yahoo_finance on July 7, 2026 11:12 AM

Read Original